MediKarma Launches Healthcare’s First Agentic AI Licensing Model
Published: 13 Jan 2026
Author: Precedence Research
The first-ever agentic AI Licensing Program in the healthcare sector has been announced by MediKarma, which represents a significant advancement in the use of AI for illness management. This novel approach enables autonomous AI agents intended to enhance patient care, preventive health, and chronic disease management to be licensed by hospital health systems, insurers, and digital health platforms. By shifting from a product-based approach to a licensing model, MediKarma is creating a new paradigm for AI-driven healthcare solutions.
Jack AI, a universal engine that can compile a patient's whole medical history in a matter of minutes using simple identifiers like name, birthdate, and ZIP code, is at the center of this project. Jack AI integrates insurance claims clinical data and even real time data from wearable devices to create a complete device to create a complete digital twin. To help healthcare providers make better decisions, this digital twin creates an actionable health profile and a validated health score that forecasts possible risks and directs tailored interventions.
Jill AI is a collection that specializes in AI agents that concentrate on health domains such as women's health, diabetes management, preventive wellness, and obesity care complements this. Directly interacting with patients, these agents provide direction reminders and assistance. According to preliminary findings, Jill AI dramatically boosts patient involvement and enhances health outcomes, illustrating how AI can convert static health data into proactive individualized care solutions.
For a healthcare organization, the licensing model also creates new opportunities. Hospitals and insurers can incorporate MediKarma's verified AI agents into their current systems, enhancing care coordination and operational effectiveness instead of creating numerous isolated tools. While healthcare systems can improve patient satisfaction and perform better quality, benchmarked insurers may benefit from lower healthcare costs and improved metrics for preventive care.
Enterprise partners can now access MediKarma's Agentic AI Licensing Program, which provides a scalable and useful way to address the rising need for proactive data-driven healthcare. With AI playing a major role in contemporary medicine, this launch puts MediKarma at the forefront of healthcare innovation and makes it possible for millions of patients worldwide to receive smarter, more individualized care.